Adherium submits US FDA 510(k) application for Ellipta® inhaler users to connect to Hailie platform with physiological parameters

Link to full article Melbourne, Australia – 7 March 2022: Adherium (ASX: ADR), a leader in respiratory eHealth, remote monitoring, and data management solutions, announces the submission to the US Food and Drug Administration (FDA) of a 510(k) clearance to market application to connect Ellipta® inhaler users with its new, next generation Hailie® sensor with […]

Adherium announces the appointment of Lou Panaccio to the Board with Matt McNamara stepping down

Link to Full Article Melbourne, Australia – 25 February 2022: Adherium Limited (“Adherium” or “the Company”; ASX: ADR), a provider of integrated digital health solutions and a world leader in connected respiratory medical devices, announces the appointment of Mr Lou Panaccio as a Non-executive director of Adherium with Mr Matthew McNamara stepping down as a […]

Manufacturing started for Hailie® for Symbicort® sensors with physiological parameters

Link to article Melbourne, Australia – 11 February 2022: Adherium Limited (ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, is pleased to announce it has completed the first production run of the next generation Hailie® sensors with physiological parameters for monitoring Asthma and Chronic Obstructive Pulmonary Disease (COPD) medication use. […]

Adherium submits US FDA 510(k) application for next generation Hailie® sensor with physiological measures

Link to Full Article Melbourne, Australia – 1 June 2021: Adherium Limited (ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, today announced submission to the US Food and Drug Administration (FDA) of a 510(k) clearance to market application for its first next generation Hailie® sensor with physiological measures for monitoring Asthma […]

Adherium announces appointment of Mr. Rick Legleiter as Chief Executive Officer and welcomes Mr. George Baran to the Board

Link to Full Article Melbourne, Australia – 13 May 2021: Adherium Limited (ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, announces the appointment of Rick Legleiter as Chief Executive Officer of Adherium. The Board also announces the appointment of George Baran as a Non-Executive Director. Mike Motion, Adherium’s current CEO and […]

Adherium Quarterly Cash Flow Report to 31 March 2021

Link to Full Article All figures are stated in Australian dollars and are unaudited.  Adherium Limited (ASX: ADR), a leader in digital inhaled device adherence, remote monitoring, and data management solutions, presents its Appendix 4C cash flow report for the quarter ended 31 March 2021. During the quarter Adherium received $18 million of investment commitments […]

Adherium introduces Hailie® technology into specialist USA respiratory centres with leading USA respiratory company

Link to Full Article Melbourne, Australia – 24 November 2020: Adherium Limited (ASX:ADR), a leader in digital inhaled device adherence, remote monitoring and data management solutions, is pleased to announce agreement of terms with leading respiratory company Monaghan Medical Corporation (Monaghan) to support the introduction of its Hailie® platform and technology into specialist respiratory centres in […]

Adherium Annual Report

Link to Full Report

Adherium appoints Mr Geoff Feakes as Chief Technology Officer

Link to Full Article Melbourne, Australia – 5 August 2020: Adherium Limited (ASX: ADR) a leader in digital inhaled device adherence, remote monitoring and data management solutions, has appointed Mr Geoff Feakes as Chief Technology Officer (CTO) leading the Company’s R&D and Innovation teams supporting Adherium’s revised business strategy. Mike Motion, Adherium CEO noted: “I […]